Crossmark

Emerging therapeutic options for refractory gout

Crossref DOI link: https://doi.org/10.1038/s41584-023-01066-5

Published Online: 2023-12-15

Published Print: 2024-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jatuworapruk, Kanon http://orcid.org/0000-0002-9301-8941
Louthrenoo, Worawit http://orcid.org/0000-0003-3105-6122
License Information

Text and Data Mining valid from 2023-12-15

Version of Record valid from 2023-12-15
More Information

Article History

First Online: 15 December 2023

Competing interests

: K.J. is a co-investigator in the EURELIA2 study (NCT05586971), sponsored by LG Chem. W.L. declares no competing interests.